These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33916346)

  • 1. Effects of Visceralising Leishmania on the Spleen, Liver, and Bone Marrow: A Pathophysiological Perspective.
    Poulaki A; Piperaki ET; Voulgarelis M
    Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33916346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
    Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
    PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host resistance to visceral leishmaniasis: prevalence and prevention.
    Maran N; Gomes PS; Freire-de-Lima L; Freitas EO; Freire-de-Lima CG; Morrot A
    Expert Rev Anti Infect Ther; 2016; 14(4):435-42. PubMed ID: 26934623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
    Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
    Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
    Zhang WW; Ghosh AK; Mohamath R; Whittle J; Picone A; Lypaczewski P; Ndao M; Howard RF; Das P; Reed SG; Matlashewski G
    BMC Infect Dis; 2018 Oct; 18(1):500. PubMed ID: 30285653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiology of leishmaniasis.
    Sharma U; Singh S
    Indian J Exp Biol; 2009 Jun; 47(6):412-23. PubMed ID: 19634705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging host-Leishmania interactions: significance in visceral leishmaniasis.
    Forestier CL
    Parasite Immunol; 2013; 35(9-10):256-66. PubMed ID: 23772814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
    Zijlstra EE
    PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood visceral leishmaniasis.
    Bhattacharya SK; Sur D; Karbwang J
    Indian J Med Res; 2006 Mar; 123(3):353-6. PubMed ID: 16778316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to leishmania: paradox rather than paradigm.
    Tripathi P; Singh V; Naik S
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):229-42. PubMed ID: 17714488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D; Alexander J
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-transmitted visceral leishmaniasis caused by Leishmania (Leishmania) mexicana in an immunocompromised patient: a case report.
    Mestra L; Lopez L; Robledo SM; Muskus CE; Nicholls RS; Vélez ID
    Transfusion; 2011 Sep; 51(9):1919-23. PubMed ID: 21392021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.
    Kong F; Saldarriaga OA; Spratt H; Osorio EY; Travi BL; Luxon BA; Melby PC
    PLoS Pathog; 2017 Jan; 13(1):e1006165. PubMed ID: 28141856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.
    Vallur AC; Tutterrow YL; Mohamath R; Pattabhi S; Hailu A; Abdoun AO; Ahmed AE; Mukhtar M; Salam MA; Almeida ML; Almeida RP; Mondal D; Albertini A; Ghalib H; Duthie MS; Reed SG
    BMC Infect Dis; 2015 Sep; 15():384. PubMed ID: 26395447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
    Datta AK; Datta R; Sen B
    Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load.
    Kumar P; Misra P; Thakur CP; Saurabh A; Rishi N; Mitra DK
    Clin Exp Immunol; 2018 Mar; 191(3):318-327. PubMed ID: 29058314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis: report of four childhood cases].
    Guo X; Chen N; Wang TY; Zhou CY; Li Q; Gao J
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):550-3. PubMed ID: 22088188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome.
    Hofman V; Marty P; Perrin C; Saint-Paul MC; Le Fichoux Y; Michiels JF; Glaichenhaus N; Pratlong F; Hofman P
    Hum Pathol; 2000 Jan; 31(1):75-84. PubMed ID: 10665917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.